NCT03545334View on ClinicalTrials.gov

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

October 31, 2020

Conditions
Malignant MelanomaMerkel Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)

Injection of ICG intradermally around the scar of the primary excision of the tumour and transcutaneous assessment of fluorescence with the VS3-3DHD camera (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System ).

Trial Locations (1)

3010

Inselspital, University Hospital Bern, University of Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03545334 - Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study | Biotech Hunter | Biotech Hunter